Brainstorm Cell Therapeutics Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2010 | $-2.1M | $-2.1M | $5.0K | $388.0K |
| FY2011 | $-2.2M | $-2.3M | $48.0K | $1.1M |
| FY2012 | $-2.9M | $-3.0M | $90.0K | $781.0K |
| FY2013 | $-4.1M | $-4.2M | $108.0K | $872.0K |
| FY2014 | $-4.5M | $-4.6M | $161.0K | $1.2M |
| FY2015 | $-7.4M | $-7.5M | $45.0K | $943.0K |
| FY2016 | $-5.9M | $-6.0M | $103.0K | $756.0K |
| FY2017 | $-2.4M | $-2.5M | $180.0K | $616.0K |
| FY2018 | $-12.4M | $-12.8M | $369.0K | $1.0M |
| FY2019 | $-11.2M | $-11.7M | $473.0K | $789.0K |
| FY2020 | $-35.2M | $-35.6M | $378.0K | $2.6M |
| FY2021 | $-26.3M | $-26.6M | $330.0K | $1.4M |
| FY2022 | $-19.3M | $-19.3M | $29.0K | $1.7M |
| FY2023 | $-20.5M | $-20.5M | $18.0K | $1.5M |
| FY2024 | $-9.1M | $-9.1M | — | $698.0K |
| FY2025 | $-7.0M | $-7.0M | — | $1.5M |